These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1078 related items for PubMed ID: 9514454

  • 1. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study).
    Jones P, Kafonek S, Laurora I, Hunninghake D.
    Am J Cardiol; 1998 Mar 01; 81(5):582-7. PubMed ID: 9514454
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR, Gandhi S, Blasetto J, Heien H, Sasane R, Nelson SP.
    Am J Geriatr Pharmacother; 2007 Sep 01; 5(3):185-94. PubMed ID: 17996658
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparing the effects of five different statins on the HDL subpopulation profiles of coronary heart disease patients.
    Asztalos BF, Horvath KV, McNamara JR, Roheim PS, Rubinstein JJ, Schaefer EJ.
    Atherosclerosis; 2002 Oct 01; 164(2):361-9. PubMed ID: 12204809
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in the treatment of patients with hypercholesterolemia: a meta-analysis of clinical trials.
    Kong SX, Crawford SY, Gandhi SK, Seeger JD, Schumock GT, Lam NP, Stubbings J, Schoen MD.
    Clin Ther; 1997 Oct 01; 19(4):778-97. PubMed ID: 9377621
    [Abstract] [Full Text] [Related]

  • 12. Treating patients with documented atherosclerosis to National Cholesterol Education Program-recommended low-density-lipoprotein cholesterol goals with atorvastatin, fluvastatin, lovastatin and simvastatin.
    Brown AS, Bakker-Arkema RG, Yellen L, Henley RW, Guthrie R, Campbell CF, Koren M, Woo W, McLain R, Black DM.
    J Am Coll Cardiol; 1998 Sep 01; 32(3):665-72. PubMed ID: 9741509
    [Abstract] [Full Text] [Related]

  • 13. Achieving and maintaining National Cholesterol Education Program low-density lipoprotein cholesterol goals with five statins.
    Andrews TC, Ballantyne CM, Hsia JA, Kramer JH.
    Am J Med; 2001 Aug 15; 111(3):185-91. PubMed ID: 11530028
    [Abstract] [Full Text] [Related]

  • 14. Safety and efficacy of atorvastatin in heart transplant recipients.
    Patel DN, Pagani FD, Koelling TM, Dyke DB, Baliga RR, Cody RJ, Lake KD, Aaronson KD.
    J Heart Lung Transplant; 2002 Feb 15; 21(2):204-10. PubMed ID: 11834348
    [Abstract] [Full Text] [Related]

  • 15. Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals.
    Shepherd J, Hunninghake DB, Barter P, McKenney JM, Hutchinson HG.
    Am J Cardiol; 2003 Mar 06; 91(5A):11C-17C; discussion 17C-19C. PubMed ID: 12646338
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the efficacy and tolerability of simvastatin and atorvastatin in the treatment of hypercholesterolemia.
    Recto CS, Acosta S, Dobs A.
    Clin Cardiol; 2000 Sep 06; 23(9):682-8. PubMed ID: 11016019
    [Abstract] [Full Text] [Related]

  • 17. Cost-effectiveness analysis of rosuvastatin versus atorvastatin, simvastatin, and pravastatin from a Canadian health system perspective.
    Costa-Scharplatz M, Ramanathan K, Frial T, Beamer B, Gandhi S.
    Clin Ther; 2008 Jul 06; 30(7):1345-57. PubMed ID: 18691996
    [Abstract] [Full Text] [Related]

  • 18. The cost of reaching National Cholesterol Education Program (NCEP) goals in hypercholesterolaemic patients. A comparison of atorvastatin, simvastatin, lovastatin and fluvastatin.
    Koren MJ, Smith DG, Hunninghake DB, Davidson MH, McKenney JM, Weiss SR, Schrott HG, Henley RW, Tresh P, McLain RW, Bakker-Arkema RG, Black DM.
    Pharmacoeconomics; 1998 Jul 06; 14(1):59-70. PubMed ID: 10182195
    [Abstract] [Full Text] [Related]

  • 19. A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial.
    Illingworth DR, Crouse JR, Hunninghake DB, Davidson MH, Escobar ID, Stalenhoef AF, Paragh G, Ma PT, Liu M, Melino MR, O'Grady L, Mercuri M, Mitchel YB, Simvastatin Atorvastatin HDL Study Group.
    Curr Med Res Opin; 2001 Jul 06; 17(1):43-50. PubMed ID: 11464446
    [Abstract] [Full Text] [Related]

  • 20. Comparison of once-daily, niacin extended-release/lovastatin with standard doses of atorvastatin and simvastatin (the ADvicor Versus Other Cholesterol-Modulating Agents Trial Evaluation [ADVOCATE]).
    Bays HE, Dujovne CA, McGovern ME, White TE, Kashyap ML, Hutcheson AG, Crouse JR, ADvicor Versus Other Cholesterol-Modulating Agents Trial Evaluation.
    Am J Cardiol; 2003 Mar 15; 91(6):667-72. PubMed ID: 12633795
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.